| 000 | 01808 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517002225.0 | ||
| 264 | 0 | _c20150922 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/apha.12421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, D-J | |
| 245 | 0 | 0 |
_aMetformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _cMar 2015 |
||
| 300 |
_a711-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aFibronectins _xblood |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aHuang, F | |
| 700 | 1 | _aLu, W-J | |
| 700 | 1 | _aJiang, G-J | |
| 700 | 1 | _aDeng, Y-P | |
| 700 | 1 | _aShen, F-M | |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 213 _gno. 3 _gp. 711-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apha.12421 _zAvailable from publisher's website |
| 999 |
_c24340330 _d24340330 |
||